Literature DB >> 35125770

Rheumatoid Arthritis with Generalized Lymphadenopathy Mimicking Lymphoma on Positron Emission Tomography/Computed Tomography with 18F-Fluorodeoxyglucose.

Luca Filippi1, Gianluca Caruso2, Oreste Bagni1, Marco Ciacciarelli3, Alessandro Polidoro3, Luigi Iuliano3.   

Abstract

A 42-year-old male presented with weight loss and progressively increasing pain and swelling in joints over the past 3 months. Contrast-enhanced computed tomography (CT) demonstrated pleuropulmonary opacities and supra/infradiaphragmatic lymph nodes enlargement. Positron emission tomography (PET/CT) with 18F-fluorodeoxyglucose showed intensely increased tracer uptake in joints, in pulmonary opacities, as well as in thoracic, iliac, and inguinal nodes. On suspicion of lymphoma with synovial involvement, he was submitted to lymph node and synovial biopsy, which revealed reactive follicular lymphadenopathy and synovium inflammatory changes, respectively. Rheumatoid factor resulted increased, and thus, diagnosis of rheumatoid arthritis with related lung and lymph node involvement was made. Copyright:
© 2021 Indian Journal of Nuclear Medicine.

Entities:  

Keywords:  18F-fluorodeoxyglucose; inflammation; lymphoma; positron emission tomography/computed tomography; rheumatoid arthritis

Year:  2021        PMID: 35125770      PMCID: PMC8771054          DOI: 10.4103/ijnm.ijnm_57_21

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


Aside its well-established role in oncology, nuclear medicine is routinely applied for imaging of infection and inflammatory diseases.[12] Inflammatory cells, such as macrophages and lymphocytes, show high 18F-fluorodeoxyglucose (18F-FDG) uptake, and therefore, positron emission tomography/computed tomography (PET/CT) has been utilized for the diagnosis and follow-up of several phlogistic conditions, including vasculitis and sarcoidosis.[3] Concerning rheumatoid arthritis, 18F-FDG PET/CT proved useful to determine disease severity and to monitor response to treatment.[4] Here, we report the case of a 42-year-old male who presented to our hospital with pain and swelling in both large and small joints, associated with weight loss over the past 3 months, and enlarged axillary and inguinal lymph nodes. He was submitted to contrast-enhanced CT that showed bilateral pulmonary opacities and enlarged lymph nodes, some of whom with rounded morphology, located in the supraclavicular, thoracic, and axillary regions, as well as along iliac and inguinal axis. PET/CT with 18F-FDG showed increased tracer uptake in large and small joints, in some pericentimeteric bilateral pleuropulmonary opacities, and in enlarged supra/infradiaphragmatic lymph nodes [Figure 1]. On suspicion of lymphoma with synovial involvement, the patient was submitted both to lymph node and synovial biopsy. Histology of one thoracic node revealed reactive follicular lymphadenopathy, thus excluding lymphoma, and biopsy of the knee synovium demonstrated inflammatory changes, mostly consisting of epithelial erosion, fibrin, and neutrophil depositions [Figure 2]. Considering the histological results, circulating level of rheumatoid factor (r.f.) was analyzed and returned increased values (372 IU/L, r.f. <30 IU/L). Therefore, diagnosis of rheumatoid arthritis with related lung involvement and lymphadenopathy was made. Treatment with prednisolone 25 mg b.i.d. was started with subsequent patient's clinical benefit.
Figure 1

Maximum intensity projection demonstrated intense tracer uptake in joint (black arrows) and in supra/infradiaphragmatic lymph nodes (black bordered arrows) (a). Fused corresponding positron emission tomography/computed tomography axial slices showed increased 18F-fluorodeoxyglucose incorporation corresponding to subsolid pulmonary lesion (b, arrow), synovial recesses as evident in the left shoulder (c, arrow), axillary and thoracic lymph nodes, some of whom with rounded morphology (d, white arrow), and in the iliac nodes, particularly in the right side (e, arrow)

Figure 2

Synovium showing inflammatory changes mostly consisting of epithelial erosion, fibrin and neutrophil depositions, increased vascularity, perivascular lymphocytes, plasma cells, and macrophages (a). Section of lymph node showing hyperplastic follicles with prominent germinative centers (b)

Maximum intensity projection demonstrated intense tracer uptake in joint (black arrows) and in supra/infradiaphragmatic lymph nodes (black bordered arrows) (a). Fused corresponding positron emission tomography/computed tomography axial slices showed increased 18F-fluorodeoxyglucose incorporation corresponding to subsolid pulmonary lesion (b, arrow), synovial recesses as evident in the left shoulder (c, arrow), axillary and thoracic lymph nodes, some of whom with rounded morphology (d, white arrow), and in the iliac nodes, particularly in the right side (e, arrow) Synovium showing inflammatory changes mostly consisting of epithelial erosion, fibrin and neutrophil depositions, increased vascularity, perivascular lymphocytes, plasma cells, and macrophages (a). Section of lymph node showing hyperplastic follicles with prominent germinative centers (b) Enlarged lymph nodes are not rare in rheumatoid arthritis. In a cohort of 100 hospitalized patients, the overall frequency of enlarged and palpable lymph nodes resulted in 82% of subjects, being the axillary region the most common location. Of note, lymphadenopathy was found associated with the grade of disease activity, being less evident in subjects under steroid therapy.[5] Furthermore, it has been reported that patients with rheumatoid arthritis present an increased risk, compared to general population, of developing both Hodgkin's lymphoma (HL) and non-HL (NHL).[6] The link between rheumatoid arthritis and lymphoma has not been fully understood yet; likely, a combination of factors, such as genetic predisposition and continuative immune stimulation, is involved in the pathogenesis.[6] On the other hand, it must be highlighted that, although rare, synovial involvement has been described in patients affected by NHL.[7] Whole-body 18F-FDG PET/CT is routinely applied for the evaluation of HL and NHL, both for staging and evaluation of response to treatment. In our patient, the highly increased tracer incorporation in multiple lymph nodes, associated also with altered rounded morphology, raised the suspicion of 18F-FDG-avid lymphoma with diffuse synovial involvement that was, however, subsequently excluded by pathology. The case reported here underscores that generalized lymphadenopathy in patients affected by RA may mimic lymphoma on PET/CT with 18F-FDG.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  7 in total

Review 1.  Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques.

Authors:  Martin Gotthardt; Chantal P Bleeker-Rovers; Otto C Boerman; Wim J G Oyen
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

2.  Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Crohn disease.

Authors:  Luca Filippi; Livia Biancone; Carmelina Petruzziello; Orazio Schillaci
Journal:  Clin Nucl Med       Date:  2006-09       Impact factor: 7.794

Review 3.  Fluorodeoxyglucose PET/CT of Arthritis in Rheumatic Diseases: A Pictorial Review.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Hiroshi Kaneko; Hiroyuki Yamashita
Journal:  Radiographics       Date:  2020 Jan-Feb       Impact factor: 5.333

Review 4.  Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.

Authors:  Kazuo Kubota; Hiroyuki Yamashita; Akio Mimori
Journal:  Semin Nucl Med       Date:  2017-04-11       Impact factor: 4.446

5.  Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M Calgüneri; M A Oztürk; Z Ozbalkan; A Akdogan; K Ureten; S Kiraz; I Ertenli
Journal:  J Int Med Res       Date:  2003 Jul-Aug       Impact factor: 1.671

6.  Non-Hodgkin Lymphoma with Synovial Involvement of the Knee.

Authors:  Brandon Kim; Bruce Raphael; Cynthia Liu; Brian D Golden
Journal:  Bull Hosp Jt Dis (2013)       Date:  2019-12

Review 7.  Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome.

Authors:  Alina Klein; Aaron Polliack; Anat Gafter-Gvili
Journal:  Hematol Oncol       Date:  2018-06-03       Impact factor: 5.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.